Gilead Sciences, Inc. (GILD)

Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Operating Revenue	30,456	29,735	29,442	29,087	28,863	28,735	28,754	28,299	27,805	27,450	27,116	27,391	27,382	27,043	27,281	27,136	27,515	27,472	27,305	27,482
Other Revenue	1	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	30,457	29,736	29,443	29,087	28,863	28,735	28,754	28,299	27,805	27,450	27,116	27,391	27,382	27,043	27,281	27,136	27,515	27,472	27,305	27,482
Revenue Growth (YoY)	5.52%	3.48%	2.40%	2.79%	3.81%	4.68%	6.04%	3.31%	1.54%	1.50%	-0.60%	0.94%	-0.48%	-1.56%	-0.09%	-1.26%	3.29%	7.46%	10.60%	18.73%
Cost of Revenue	6,212	6,135	6,230	6,191	6,196	6,239	6,251	6,230	6,221	6,119	5,968	5,804	5,634	5,634	5,657	5,638	5,641	5,589	5,526	4,666
Gross Profit	24,245	23,601	23,213	22,896	22,667	22,496	22,503	22,069	21,584	21,331	21,148	21,587	21,748	21,409	21,624	21,498	21,874	21,883	21,779	22,816
Selling, General & Admin	6,460	5,912	5,708	5,792	5,850	5,860	6,000	5,719	5,624	6,105	6,062	6,502	6,401	5,909	5,673	5,303	5,280	5,274	5,246	5,083
Research & Development	5,944	5,704	5,688	5,734	5,786	5,685	5,816	5,655	5,728	5,778	5,758	5,895	5,578	5,280	4,977	4,768	4,727	4,714	4,601	4,655
Operating Expenses	12,404	11,616	11,396	11,526	11,636	11,545	11,816	11,374	11,352	11,883	11,820	12,397	11,979	11,189	10,650	10,071	10,007	9,988	9,847	9,738
Operating Income	11,841	11,985	11,817	11,370	11,031	10,951	10,687	10,695	10,232	9,448	9,328	9,190	9,769	10,220	10,974	11,427	11,867	11,895	11,932	13,078
Interest Expense	-998	-1,004	-1,024	-1,018	-999	-983	-977	-980	-976	-968	-944	-918	-914	-927	-935	-947	-968	-982	-1,001	-1,030
Interest & Investment Income	323	350	349	339	303	267	281	298	352	406	376	650	544	454	106	-	-	-	-	-
Currency Exchange Gain (Loss)	3	-16	-29	-17	-21	1	14	-2	3	-6	-12	-	-91	-40	-	-13	21	-38	-23	-30
Other Non Operating Income (Expenses)	-7	8	27	21	21	-	-15	-2	-13	-6	2	-339	-216	-241	-30	38	-29	12	-6	47
EBT Excluding Unusual Items	11,162	11,323	11,140	10,695	10,335	10,236	9,990	10,009	9,598	8,874	8,750	8,583	9,092	9,466	10,115	10,505	10,891	10,887	10,902	12,065
Merger & Restructuring Charges	-108	-103	-138	-177	-191	-200	-189	-691	-663	-641	-527	-	-	-	-	-	-	-	-	-1,290
Gain (Loss) on Sale of Investments	1,220	1,019	451	72	-153	-681	-274	41	-385	70	-167	-417	-445	-817	-657	-539	-484	-355	-610	-1,283
Asset Writedown	-	-	-	-	-	-	-	-	-	-	-51	-	-	-	-	-	-	-	-	-
Legal Settlements	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,250	-1,075	-1,075	-1,075	175
Other Unusual Items	-80	-44	-43	-40	-41	5	7	69	76	57	60	37	27	34	-	-19	-12	-10	-	-
Pretax Income	-1,955	10,727	9,796	9,886	7,201	6,825	691	177	1,539	1,075	6,860	7,237	7,351	7,266	5,814	4,542	5,548	5,862	8,278	9,333
Income Tax Expense	1,285	1,511	1,286	1,776	890	860	211	63	505	616	1,247	1,408	1,909	1,728	1,248	1,233	1,439	1,371	2,077	1,964
Earnings From Continuing Operations	-3,240	9,216	8,510	8,110	6,311	5,965	480	114	1,034	459	5,613	5,829	5,442	5,538	4,566	3,309	4,109	4,491	6,201	7,369
Minority Interest in Earnings	-	-	-	-	-	-	-	12	20	26	52	47	42	45	26	25	28	24	24	25
Net Income	-3,240	9,216	8,510	8,110	6,311	5,965	480	126	1,054	485	5,665	5,876	5,484	5,583	4,592	3,334	4,137	4,515	6,225	7,394
Net Income to Common	-3,240	9,216	8,510	8,110	6,311	5,965	480	126	1,054	485	5,665	5,876	5,484	5,583	4,592	3,334	4,137	4,515	6,225	7,394
Net Income Growth (YoY)	-	54.50%	1672.92%	6336.51%	498.77%	1129.90%	-91.53%	-97.86%	-80.78%	-91.31%	23.37%	76.24%	32.56%	23.65%	-26.23%	-54.91%	-19.86%	1400.00%	4960.98%	483.12%
Shares Outstanding (Basic)	1,243	1,243	1,244	1,246	1,247	1,247	1,247	1,247	1,247	1,248	1,248	1,251	1,252	1,253	1,255	1,255	1,256	1,256	1,256	1,256
Shares Outstanding (Diluted)	1,243	1,254	1,255	1,262	1,260	1,258	1,255	1,249	1,252	1,255	1,258	1,261	1,262	1,262	1,262	1,261	1,262	1,262	1,262	1,267
Shares Change (YoY)	-1.39%	-0.34%	-	1.02%	0.68%	0.28%	-0.24%	-0.91%	-0.79%	-0.57%	-0.32%	-0.06%	-0.04%	-0.02%	-	-0.43%	-0.20%	0.08%	-0.08%	0.44%
EPS (Basic)	-2.61	7.41	6.84	6.51	5.06	4.78	0.38	0.10	0.85	0.39	4.54	4.70	4.38	4.45	3.66	2.66	3.30	3.60	4.96	5.89
EPS (Diluted)	-2.61	7.35	6.78	6.42	5.01	4.73	0.38	0.10	0.84	0.39	4.50	4.67	4.35	4.42	3.64	2.64	3.27	3.58	4.93	5.84
EPS Growth (YoY)	-	55.43%	1684.21%	6514.05%	496.80%	1118.07%	-91.56%	-97.92%	-80.70%	-91.21%	23.63%	76.89%	32.97%	23.47%	-26.17%	-54.83%	-19.93%	1393.25%	4938.22%	480.44%

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Free Cash Flow	12,943	10,230	9,456	9,162	9,369	9,844	10,305	9,431	6,896	7,900	7,421	7,853	8,926	8,386	8,344	9,007	9,415	9,953	10,805	9,491
Free Cash Flow Per Share	10.42	8.16	7.54	7.26	7.44	7.83	8.21	7.55	5.51	6.30	5.90	6.23	7.08	6.65	6.61	7.14	7.46	7.89	8.56	7.49
Dividend Per Share	3.220	3.190	3.160	3.140	3.120	3.100	3.080	3.060	3.040	3.020	3.000	2.980	2.960	2.940	2.920	2.900	2.880	2.860	2.840	2.810
Dividend Growth (YoY)	3.21%	2.90%	2.60%	2.61%	2.63%	2.65%	2.67%	2.69%	2.70%	2.72%	2.74%	2.76%	2.78%	2.80%	2.82%	3.20%	3.60%	4.00%	4.41%	5.24%
Gross Margin	79.60%	79.37%	78.84%	78.72%	78.53%	78.29%	78.26%	77.98%	77.63%	77.71%	77.99%	78.81%	79.42%	79.17%	79.26%	79.22%	79.50%	79.66%	79.76%	83.02%
Operating Margin	38.88%	40.30%	40.13%	39.09%	38.22%	38.11%	37.17%	37.79%	36.80%	34.42%	34.40%	33.55%	35.68%	37.79%	40.23%	42.11%	43.13%	43.30%	43.70%	47.59%
Profit Margin	-10.64%	30.99%	28.90%	27.88%	21.87%	20.76%	1.67%	0.45%	3.79%	1.77%	20.89%	21.45%	20.03%	20.64%	16.83%	12.29%	15.04%	16.43%	22.80%	26.91%
Free Cash Flow Margin	42.50%	34.40%	32.12%	31.50%	32.46%	34.26%	35.84%	33.33%	24.80%	28.78%	27.37%	28.67%	32.60%	31.01%	30.59%	33.19%	34.22%	36.23%	39.57%	34.53%
EBITDA	14,601	14,738	14,577	14,136	13,801	13,724	13,454	13,457	12,988	12,191	12,021	11,723	12,143	12,438	13,077	13,537	13,975	13,997	13,982	15,020
EBITDA Margin	47.94%	49.56%	49.51%	48.60%	47.82%	47.76%	46.79%	47.55%	46.71%	44.41%	44.33%	42.80%	44.35%	45.99%	47.93%	49.89%	50.79%	50.95%	51.21%	54.65%
D&A For EBITDA	2,760	2,753	2,760	2,766	2,770	2,773	2,767	2,762	2,756	2,743	2,693	2,533	2,374	2,218	2,103	2,110	2,108	2,102	2,050	1,942
EBIT	11,841	11,985	11,817	11,370	11,031	10,951	10,687	10,695	10,232	9,448	9,328	9,190	9,769	10,220	10,974	11,427	11,867	11,895	11,932	13,078
EBIT Margin	38.88%	40.30%	40.13%	39.09%	38.22%	38.11%	37.17%	37.79%	36.80%	34.42%	34.40%	33.55%	35.68%	37.79%	40.23%	42.11%	43.13%	43.30%	43.70%	47.59%
Effective Tax Rate	-	14.09%	13.13%	17.96%	12.36%	12.60%	30.54%	35.59%	32.81%	57.30%	18.18%	19.46%	25.97%	23.78%	21.46%	27.15%	25.94%	23.39%	25.09%	21.04%
Revenue as Reported	30,457	29,736	29,443	29,087	28,863	28,735	28,754	28,299	27,805	27,450	27,116	27,391	27,382	27,043	27,281	27,136	27,515	27,472	27,305	27,482
Advertising Expenses	-	-	1,000	-	-	-	869	-	-	-	826	-	-	-	778	-	-	-	735	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error